Atlas Trials

Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer

Clinical trial NCT02355119 · UNKNOWN

Trial details

NCT number
NCT02355119
Sponsor
Azienda Ospedaliero, Universitaria Pisana
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2015-01-01
Primary completion
2017-12-01
Enrollment
310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.